Impact of amiodarone use on metoprolol concentrations, α‐OH‐metoprolol concentrations, metoprolol dosing and heart rate: A cross‐sectional study
Abstract Small studies suggest that amiodarone is a weak inhibitor of cytochrome P450 (CYP) 2D6. Inhibition of CYP2D6 leads to increases in concentrations of drugs metabolized by the enzyme, such as metoprolol. Considering that both metoprolol and amiodarone have β‐adrenergic blocking properties and...
Saved in:
Main Authors: | Sabrina Robert (Author), Marc‐Olivier Pilon (Author), Essaïd Oussaïd (Author), Maxime Meloche (Author), Grégoire Leclair (Author), Martin Jutras (Author), Marie‐Josée Gaulin (Author), Ian Mongrain (Author), David Busseuil (Author), Jean‐Claude Tardif (Author), Marie‐Pierre Dubé (Author), Simon deDenus (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2023-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Females present higher dose‐adjusted drug concentrations of metoprolol and allopurinol/oxypurinol than males
by: Jessica Hindi, et al.
Published: (2023) -
Leveraging large observational studies to discover genetic determinants of drug concentrations: A proof‐of‐concept study
by: Maxime Meloche, et al.
Published: (2022) -
An association study of ABCG2 rs2231142 on the concentrations of allopurinol and its metabolites
by: Marc‐Olivier Pilon, et al.
Published: (2022) -
Health expenditure comparison of extended-release metoprolol succinate and immediate-release metoprolol tartarate
by: Vaidya V, et al.
Published: (2012) -
Mitochondrial Disorder Aggravated by Metoprolol
by: Cheryl Samuels, et al.
Published: (2016)